Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
![Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/8fc6c8fc-4278-46f3-8889-44b9eb1ec507/fx1_lrg.jpg)
Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
![PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model](https://i1.rgstatic.net/publication/309957914_Hemolytic_anemia_repressed_hepcidin_level_without_hepatocyte_iron_overload_Lesson_from_Gunther_disease_model/links/5e1ee05692851c3cbe657577/largepreview.png)
PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the Europ
![PDF) Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan | Mohammed Naja - Academia.edu PDF) Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan | Mohammed Naja - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/51232148/mini_magick20190126-6719-lv2afz.png?1548494384)